Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP, Corp. Controller & CAO | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,196 |
Ending reported balance
After 2026-03-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-04 · Grant · Acquired 1,473 · Balance 35,946 F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2026-03-04 · Tax withholding · Disposed 750 · Balance 35,196 F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 750 | $204.86 | $153,645.00 |
DisclosureSEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 2 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,196 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,473 | $204.86 | $301,758.78 |
DisclosureSEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 1 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,946 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 88 | $204.86 | $18,027.68 |
DisclosureSEC source: 0001022079-26-000017 · wk-form4_1772660229.xml · nonDerivative · entry 1 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,473 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 1,688 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · derivative · entry 5 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,688 Underlying: Common Stock · 1,688 shares Expires 2036-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 99 | $206.99 | $20,492.01 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 3 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,560 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 83 | $210.01 | $17,430.83 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 2 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,659 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 1 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,742 F1 · security: Represents an award of restricted stock units. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 867 | $173.74 | $150,632.58 |
DisclosureSEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,365 F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,711 | $173.74 | $297,269.14 |
DisclosureSEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,232 F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,692 | $173.74 | $293,968.08 |
DisclosureSEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,521 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 88 | $171.75 | $15,114.00 |
DisclosureSEC source: 0001022079-25-000070 · wk-form4_1740778439.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,212 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 99 | $169.71 | $16,801.29 |
DisclosureSEC source: 0001022079-25-000050 · wk-form4_1740173971.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,300 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 1,738 | $0.00 Strike: $165.30 | $0.00 |
DisclosureSEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,738 Underlying: Common Stock · 1,738 shares Expires 2035-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,399 F1 · security: Represents an award of restricted stock units. F2 · balance_after: This amount includes previous exempt purchases made under the Company's stock purchase plan (the "plan") that were transferred out of the plan and into a brokerage account held by Reporting Person since the date of the last filing on Form 4. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 10,120 | $66.51 Strike: $66.51 | $673,081.20 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · derivative · entry 11 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,120 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 26, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 8,635 | $71.17 Strike: $71.17 | $614,552.95 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · derivative · entry 10 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,635 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,189 | $154.74 | $802,958.31 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 8 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,941 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F6 · price: This transaction was executed in multiple trades at prices ranging from $154.460 - $155.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,331 | $154.03 | $359,046.26 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 7 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,130 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,600 | $152.71 | $397,049.90 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 6 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,461 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F5 · price: This transaction was executed in multiple trades at prices ranging from $152.400 to $153.170. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,135 | $154.74 | $639,833.36 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 5 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,061 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $154.460 to $155.180. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,400 | $153.98 | $369,558.96 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,196 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,100 | $152.70 | $320,676.09 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,596 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $152.400 to $153.200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 10,120 | $66.51 | $673,081.20 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 8,635 | $71.17 | $614,552.95 |
DisclosureSEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 57 | $126.36 | $7,202.52 |
DisclosureSEC source: 0001022079-24-000078 · wk-form4_1709329341.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,930 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 52 | $126.36 | $6,570.72 |
DisclosureSEC source: 0001022079-24-000078 · wk-form4_1709329341.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,987 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 631 | $125.02 | $78,887.62 |
DisclosureSEC source: 0001022079-24-000062 · wk-form4_1709069467.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,039 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,689 | $125.02 | $211,158.78 |
DisclosureSEC source: 0001022079-24-000062 · wk-form4_1709069467.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,670 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 89 | $125.02 | $11,126.78 |
DisclosureSEC source: 0001022079-24-000049 · wk-form4_1708723821.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,981 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 2,322 | $0.00 Strike: $127.81 | $0.00 |
DisclosureSEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,322 Underlying: Common Stock · 2,322 shares Expires 2034-02-14 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,070 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 682 | $147.86 | $100,840.52 |
DisclosureSEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,497 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,918 | $147.86 | $283,595.48 |
DisclosureSEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,178 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 68 | $140.69 | $9,566.92 |
DisclosureSEC source: 0001022079-23-000046 · wf-form4_167787971519132.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,260 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:46 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 1,960 | $0.00 Strike: $143.33 | $0.00 |
DisclosureSEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · derivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,960 Underlying: Common Stock · 1,960 shares Expires 2033-02-23 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:46 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,328 F2 · security: Represents an award of restricted share units. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:46 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 188 | $147.86 | $27,797.68 |
DisclosureSEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,825 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 6,371 | $56.12 Strike: $56.12 | $357,540.52 |
DisclosureSEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · derivative · entry 6 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,371 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 9,126 | $52.17 Strike: $52.17 | $476,057.79 |
DisclosureSEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · derivative · entry 5 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,126 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 15,497 | $145.00 | $2,247,065.00 |
DisclosureSEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,013 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,371 | $56.12 | $357,540.52 |
DisclosureSEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 9,126 | $52.17 | $476,057.79 |
DisclosureSEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 8 | $136.98 | $1,095.84 |
DisclosureSEC source: 0001022079-22-000097 · wf-form4_165307945293358.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,006 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 79 | $130.09 | $10,277.11 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,011 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 206 | $130.09 | $26,798.54 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,089 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 835 | $130.09 | $108,625.15 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,883 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,310 | $130.09 | $300,507.90 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,718 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 2,654 | $0.00 Strike: $127.73 | $0.00 |
DisclosureSEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · derivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,654 Underlying: Common Stock · 2,654 shares Expires 2032-02-24 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,408 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 549 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,276 F1 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.